A nurse is caring for a patient who has been receiving continuous IV heparin therapy for deep vein thrombosis. The patient's most recent aPTT result is 120 seconds (normal range: 25-35 seconds), and the nurse notices the patient has developed multiple small bruises on both arms and reports feeling dizzy when standing. Which action should the nurse take first?

An aPTT of 120 seconds indicates significant heparin overdose, requiring immediate discontinuation to prevent bleeding. Other options are secondary interventions after stopping the infusion.

Understanding the Situation
The patient is on a continuous IV heparin infusion for deep vein thrombosis (DVT). The activated partial thromboplastin time (aPTT) is critically elevated at 120 seconds, far exceeding the typical therapeutic range of 1.5 to 2.5 times the control value (which would be approximately 46 to 70 seconds based on a normal of 25-35 seconds). This indicates a state of significant over-anticoagulation. The clinical signs of multiple new bruises and dizziness upon standing (a potential sign of orthostatic hypotension from hypovolemia) suggest the patient is actively experiencing a major hemorrhagic complication.

Prioritizing the First Action
In any situation where a medication infusion is causing a life-threatening adverse effect, the nurse's immediate priority is to stop the source of the problem. The foundational principle of emergency management is to remove the causative agent. Continuing the heparin infusion, even for a few more minutes, will deliver more anticoagulant into the patient's system, worsening the bleeding. The scenario describes a patient with a supratherapeutic aPTT and clinical signs of bleeding, which constitutes a medical emergency. The first and most critical nursing action is to stop the heparin infusion immediately. This directly halts the administration of the drug causing the over-anticoagulation and active bleeding [3,4].

Analyzing the Incorrect Options
- Option 1 (Administer protamine sulfate as ordered): While protamine sulfate is the specific reversal agent for unfractionated heparin, it is not the first action. The heparin infusion must be stopped first; otherwise, the protamine will be attempting to neutralize a drug that is still being actively infused. Furthermore, protamine administration is a dependent nursing action requiring a specific provider order, and the immediate, independent nursing action is to discontinue the source of harm.
- Option 2 (Increase the frequency of neurological assessments): This action addresses monitoring for a complication (such as intracranial hemorrhage) but does not treat the underlying cause. While neurological assessment is important in a bleeding patient, it is a secondary intervention. The immediate priority is to stop the ongoing administration of the anticoagulant to prevent further clinical deterioration.
- Option 3 (Document the findings and continue current therapy): This action is dangerous and contraindicated. The aPTT of 120 seconds is a critical value, and the presence of bruising and dizziness indicates active bleeding. Continuing the therapy would be a failure to recognize and respond to a life-threatening emergency. Documentation is always performed after the patient is stabilized.

Clinical Reasoning and Evidence Connection
The management of bleeding due to unfractionated heparin (UFH) is a high-priority safety concern. The core principle is immediate cessation of the drug. The provided evidence underscores the critical importance of monitoring and managing anticoagulation to prevent such emergencies. One study highlights the need for prompt evaluation of heparin’s effect, specifically in cases of life-threatening bleeding, to guide urgent clinical decisions . Another source details the complexity of achieving a therapeutic anticoagulation range with UFH and the risk of bleeding when levels become supratherapeutic, reinforcing that the first step in managing over-anticoagulation is stopping the infusion . Evidence-based guidelines for managing venous thromboembolism universally prioritize patient safety by structuring care around the immediate identification and mitigation of hemorrhagic risk, which begins with discontinuing the offending agent [2,4].